|
 |
| home > ebr > summer 2004 > a discussion of the ethical issues which surround pharmacogenetics |
 |
 |
PUBLICATIONS |
European BioPharmaceutical Review
|
| People often respond differently to the same medicine. Few medicines are effective for everyone and all may cause adverse reactions or even, occasionally, death. Pharmacogenetics, the study of genetic variation between individuals that affects response to medicines, has the potential to play an important role in improving safety and efficacy. Not only do adverse reactions to medicines have significant costs, in both human and monetary terms, but considerable resources are wasted on prescribing medicines that have little or no effect for particular patients. |
Read full article >>
|
 |
 |
 |
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
 |

 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
BASi Opens New Office in Europe
12th November 2008
More info >> |
|
|